产品编号：N519947
产品规格：50mg
产品价格：面议
| 标准品编号: | N519947 |
| 名称: | 4-(6-Nitro-3-pyridinyl)-1-piperazine-2,2,6,6-d4-carboxylic Acid 1,1-Dimethylethyl Ester |
| 别名: | 4-(6-Nitro-3-pyridinyl)-1-piperazinecarboxylic Acid-d4 1,1-Dimethylethyl Ester; 4-(6-Nitropyridin-3-yl)piperazine-1-carboxylic-d4 Acid t-Butyl Ester; t-Butyl 4-(6-Nitro-3-pyridyl)piperazine-1-carboxylate-d4; t-Butyl 4-(6-Nitropyridin-3-yl)piperazine-1-carboxylate-d4 |
| CAS号: | 2089333-15-1 |
| 参考CAS号: | 类似: 571189-16-7 |
| 分子式: | C₁₄H₁₆D₄N₄O₄ |
| 外观: | Yellow Solid |
| 分子量: | 312.36 |
| 溶解度: | Dichloromethane; Ethyl Acetate; Methanol |
| 种类: | Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | 4-(6-Nitro-3-pyridinyl)-1-piperazine-2,2,6,6-d4-carboxylic Acid 1,1-Dimethylethyl Ester is an intermediate in synthesizing Palbociclib-d4 (P139901), an isotope labelled compound of Palbociclib (P139900). Palbociclib (P139900) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. |
| 参考文献 | |
